VRCA Q2 EPS Forecast Boosted by Brookline Capital Management
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Free Report) – Equities research analysts at Brookline Capital Management upped their Q2 2025 earnings estimates for shares of Verrica Pharmaceuticals in a note issued to investors on Wednesday, May 14th. Brookline Capital Management analyst K. Dolliver now expects that the company will earn ($0.07) per share for the quarter, […]
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Free Report) – Equities research analysts at Brookline Capital Management upped their Q2 2025 earnings estimates for shares of Verrica Pharmaceuticals in a note issued to investors on Wednesday, May 14th. Brookline Capital Management analyst K. Dolliver now expects that the company will earn ($0.07) per share for the quarter, […]
